Cluster III had the highest proportion of ETV6-RUNX1 (41%), followed by hyperdiploid ALL (23%), likely consisting of low-risk ALLs that are chemotherapy-sensitive. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.